Everest Medicines announced Executive Changes. The company appointed Dr. Jason Brown, who served as Senior Vice President of Business Development has been named the company’s Chief Business Officer. Additionally, the company announced four senior leadership appointments, naming Dr. Frank Grams as Senior Vice President of Alliance Management and Head of Business Development in Europe. He most recently served as the Vice President, Global Head of Alliance Management for General Medicines & Emerging Markets and Global Head of R&D Alliance Management at Sanofi. Sophia Zhu as Senior Vice President of Portfolio Development and Strategic Planning. Before joining Everest Medicines, Ms. Zhu served as the Head of Strategic Portfolio Development, Specialty Care at Sanofi China. Before that, she served as Director of Worldwide Commercialization, Hepatitis C at Bristol-Myers Squibb. Alex Wang as Head of International Business Previously, he served as the General Manager of Abbott’s Singapore-based Point-of-Care Division in the Asia Pacific and Daniel Weng as Vice President of Finance. Before joining Everest Medicines, he served as Head of Finance for Amgen China, where he was responsible for overall financial operations related to commercial operation, research & development activities and strategic collaborations.